Latest filing published 19 Jun 2016 for Zenith Epigenetics Corp., €30k.
No signal scores available.
This profile gathers the share dealings of Donald J. Mccaffrey in Zenith Epigenetics Corp. We count 4 filings; the first trade dates from 29 January 2016 and the latest from 14 June 2016.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 19 June 2016, reports an option exercise of €30k in Zenith Epigenetics Corp. The median gap between a trade and its publication by SEDI is 5 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations